January 26, 2015 8:52 PM ET

Pharmaceuticals

Company Overview of Ardent Pharmaceuticals, Inc.

Company Overview

Ardent Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of delta receptor compounds. It develops a range of drugs for use in moderate to severe pain, urinary incontinence, premature ejaculation, depression, cardioprotection, glaucoma, neuroprotection, immunomodulation, and drug abuse. The company’s DPI-3290 IV formulation is used for acute pain. Ardent Pharmaceuticals, Inc. was formerly known as Delta Pharmaceuticals, Inc. The company is based in Durham, North Carolina. As of 12/20/2004, Ardent Pharmaceuticals, Inc. is a subsidiary of Enhance Biotech, Inc.

631 United Drive

Suite 200

Durham, NC 27713

United States

Phone:

919-806-1806

Fax:

919-806-1161

Key Executives for Ardent Pharmaceuticals, Inc.

Chief Financial Officer
Chief Medical Officer and Senior Vice President for Clinical Development
Age: 63
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
E. R. Squibb & Sons Inter-American Corporation United States
Karos Pharmaceuticals, Inc. United States
Cherokee Pharma, LLC United States
Catena Pharmaceuticals, Inc. United States
Roxlor, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ardent Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.